842 results
Page 5 of 43
8-K
EX-99.1
fv3 2opxj
2 May 19
Teva Reports First Quarter 2019 Financial Results
7:00am
8-K
EX-10.1
1w3ak2ryn5
10 Apr 19
Entry into a Material Definitive Agreement
8:01am
8-K
EX-99.1
fw44ha3dwo7p2rjg
13 Feb 19
Teva Reports Fourth Quarter and Full Year 2018 Financial Results
7:00am
8-K
EX-3.2
xgm5bd18
14 Dec 18
Material Modifications to Rights of Security Holders
7:51am
8-K
EX-3.3
dsw3hy5arkewo5kr
14 Dec 18
Material Modifications to Rights of Security Holders
7:51am
8-K
EX-4.1
cb5kbdl
4 Dec 18
Material Modifications to Rights of Security Holders
4:24pm
F-6
EX-99
hkcac06oln74e4fb8t
13 Nov 18
Registration for ADRs (foreign)
4:25pm
F-6
EX-99
qrzeekno c8
13 Nov 18
Registration for ADRs (foreign)
4:25pm
8-K
EX-99.1
lfdohwqp0vqv
1 Nov 18
Teva Reports Third Quarter 2018 Financial Results
7:02am
8-K
EX-99.1
gkqz74
2 Aug 18
Teva Reports Second Quarter 2018 Financial Results
7:00am
10-Q
ch1tnshmla29lxfl
3 May 18
Quarterly report
4:08pm
8-K
EX-99.1
t7cv6v06m4lrqr pa
3 May 18
Teva Reports First Quarter 2018 Financial Results
12:00am
DEF 14A
cpjqvp92tpe
25 Apr 18
Definitive proxy
12:00am
DEFA14A
81efsp i3e
25 Apr 18
Additional proxy soliciting materials
12:00am
424B3
tipjt7jvoel1nd
19 Apr 18
Prospectus supplement
12:00am